AMENDMENT NO. 2 TO TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • May 16th, 2006 • Mylan Laboratories Inc • Pharmaceutical preparations • Pennsylvania
Contract Type FiledMay 16th, 2006 Company Industry JurisdictionTHIS AMENDMENT NO. 2 TO TRANSITION AND SUCCESSION AGREEMENT (this “Amendment”) by and between Mylan Laboratories Inc., a Pennsylvania corporation (the “Company”), and John P. O’Donnell (the “Executive”), is made as of April 3, 2006.
AMENDMENT NO. 2 TO TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • May 16th, 2006 • Mylan Laboratories Inc • Pharmaceutical preparations • Pennsylvania
Contract Type FiledMay 16th, 2006 Company Industry JurisdictionTHIS AMENDMENT NO. 2 TO TRANSITION AND SUCCESSION AGREEMENT (this “Amendment”) by and between Mylan Laboratories Inc., a Pennsylvania corporation (the “Company”), and Edward J. Borkowski (the “Executive”), is made as of April 3, 2006.
AMENDMENT NO. 2 TO TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • May 16th, 2006 • Mylan Laboratories Inc • Pharmaceutical preparations • Pennsylvania
Contract Type FiledMay 16th, 2006 Company Industry JurisdictionTHIS AMENDMENT NO. 2 TO TRANSITION AND SUCCESSION AGREEMENT (this “Amendment”) by and between Mylan Laboratories Inc., a Pennsylvania corporation (the “Company”), and Louis J. DeBone (the “Executive”), is made as of April 3, 2006.